08 Jul Molecular Cloning Systems Gets Distributor
MIDDLETON, WI –Lucigen Corporation, a developer and manufacturer of molecular cloning systems and Massachusetts-based Agencourt Bioscience, which develops genomic services and products announced a new alliance in which Agencourt will be the sole distributor of Lucigen’s CloneSmart cloning kits and research products.
Researchers often encounter certain genes, chromosomal regions or entire genomes that are especially difficult to clone. Lucigen’s CloneSmart technology was designed specifically to eliminate many of the difficulties inherent to cloning, from an individual gene or a complete genome. The technology utilizes a series of low-background vectors designed to clone sequences that are difficult to clone with conventional vectors.
“Our collaboration with Lucigen to leverage their unique single cell genomics technology will provide Agencourt with an innovative platform for the discovery and development of novel bioproducts to add to our growing products base,” said Paul McEwan, co-chief scientific officer for Agencourt.
“Agencourt has established a leadership position in high throughput sequence capabilities, which nicely complements Lucigen’s growing Single Cell Genomics discovery program,” said Dr. David Mead, president of Lucigen.
Agencourt Bioscience Corporation is a provider of genomic services and nucleic acid purification products that help biotech and pharmaceutical companies improve the process of drug development. The company’s products and services are based on the patented Solid Phase Reversible Immobilization (SPRI) technology, which has been used to sequence over 20 billion base pairs of DNA.
Lucigen’s business is discovering, developing, and marketing enzymes and enzyme-related products for global biomedical research, biopharmaceuticals, and diagnostics. Lucigen invented the DNA cloning technologies that are incorporated into its current CloneSmart gene cloning and genomics products, PicoClone cloning services, and Single Cell Genomics technology for new product discovery. The company has been awarded over $2 million in SBIR (Small Business Innovative Research) grants from the National Institutes of Health, National Science Foundation, and the US Department of Energy.
Jamie is a freelance technology writer and regular contributor to the Wisconsin Technology Network. She is also an English/Linguistics major at the University of Wisconsin-Madison. She can be reached at Jamie Hofmeister.